Arcus Biosciences, Inc.'s (NYSE:RCUS) Latest 8.6% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures

Yahoo FinanceMar 29 09:44 ET

Arcus Biosciences Management to Meet With Cantor Fitzgerald

TipRanksMar 25 16:40 ET

Arcus Biosciences Announces New Employment Inducement Grants

BusinesswireMar 25 16:35 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), ATyr Pharma (ATYR) and Lyra Therapeutics (LYRA)

TipRanksMar 14 07:00 ET · Ratings

Little Excitement Around Arcus Biosciences, Inc.'s (NYSE:RCUS) Revenues As Shares Take 26% Pounding

Simply Wall StMar 6 05:22 ET

Morgan Stanley Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Cuts Target Price to $24

Moomoo NewsMar 3 08:31 ET · Ratings